Thrombocytes, universally known as platelets, are the smallest formed elements found in human blood. Despite lacking a nucleus, these anucleate cell fragments play an indispensable role in maintaining vascular integrity and stopping bleeding. Normal adult peripheral blood typically contains between 150,000 and 400,000 platelets per microliter. Produced continuously in the red bone marrow, they have a normal lifespan of about 8 to 10 days before old or damaged platelets are removed by macrophages in the spleen and liver.
Platelets originate from massive bone marrow precursors called megakaryocytes. The process of their development, known as megakaryopoiesis, is heavily regulated by the hormone thrombopoietin, which is produced primarily by the liver and kidneys. Megakaryocytes undergo endomitosis—replicating their DNA without undergoing cell division—becoming giant polyploid cells. During final maturation, these cells extend long, branching cytoplasmic projections called proplatelets into the blood sinusoids, where shear stress breaks them apart into thousands of individual platelets.
When a blood vessel wall is injured, primary hemostasis kicks in instantly to halt bleeding. This process unfolds in three rapid phases:
Primary hemostasis forms a temporary plug, but it requires reinforcement through secondary hemostasis. This involves the coagulation cascade, a series of enzymatic reactions involving plasma clotting factors that culminate in the conversion of soluble fibrinogen into insoluble fibrin threads. These threads weave tightly through and around the platelet plug. Activated platelets also provide a phospholipid surface that accelerates these reactions, leading to clot retraction and eventual wound healing.
Imbalances in platelet counts lead to significant clinical disorders. Thrombocytopenia refers to an abnormally low platelet count, commonly resulting from decreased bone marrow production, increased destruction, or splenic sequestration. Patients with severe thrombocytopenia present with petechiae, purpura, and spontaneous mucosal bleeding. Conversely, thrombocytosis involves an excessively high platelet count, which can be reactive due to inflammation or iron deficiency, or primary due to bone marrow proliferative disorders, raising the risk of abnormal thrombosis.
Midwives must carefully monitor laboratory values and clinical signs related to clotting function, especially in pregnant women at risk for postpartum hemorrhage or preeclampsia. Midwives should inspect postpartum clients for excessive lochia, unexplained bruising, or bleeding gums. When caring for women receiving anticoagulant therapy or those with gestational thrombocytopenia, monitoring full blood counts and screening for signs of hemorrhage is a core clinical responsibility to ensure maternal safety.